Sign In
Last checked at 
3 Jun 2008 10:04
NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY OR CONNECTED PERSONS
This form is intended for use by an issuer to make a RIS notification required by DR 3.1.4R(1).
|
(1) |
An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24. |
|
(2) |
An issuer making a notification in respect of a derivative relating to the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14, 16, 23 and 24. |
|
(3) |
An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24. |
|
(4) |
An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24. |
Please complete all relevant boxes in block capital letters.
1. Name of the issuer
PHYTOPHARM PLC
2. State whether the notification relates to (i) a transaction notified in accordance with DR 3.1.4R(1)(a); or (ii) DR 3.1.4(R)(1)(b) a disclosure made in accordance with section 324 (as extended by section 328) of the Companies Act 1985; or (iii) both (i) and (ii)
(III) BOTH (I) AND (II)
3. Name of person discharging managerial responsibilities/director
DR DARYL REES, CHIEF EXECUTIVE
4. State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person
AS 3 ABOVE
5. Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial interest
AS 3 ABOVE
6. Description of shares (including class), debentures or derivatives or financial instruments relating to shares
OPTIONS OVER ORDINARY SHARES OF 1 PENCE EACH
7. Name of registered shareholders(s) and, if more than one, the number of shares held by each of them
8 State the nature of the transaction
9. Number of shares, debentures or financial instruments relating to shares acquired
10. Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage)
11. Number of shares, debentures or financial instruments relating to shares disposed
12. Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage)
13. Price per share or value of transaction
14. Date and place of transaction
15. Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage)
16. Date issuer informed of transaction
If a person discharging managerial responsibilities has been granted options by the issuer complete the following boxes
17 Date of grant
30 MAY 2008
18. Period during which or date on which it can be exercised
THESE SHARES SHALL BE TRANSEFRRED TO DR REES AT THE END OF THE PERFORMANCE PERIOD TO THE EXTENT THAT THE PERFORMANCE CRITERIA HAVE BEEN SATISFIED
19. Total amount paid (if any) for grant of the option
NIL
20. Description of shares or debentures involved (class and number)
150,000 PHYTOPHARM PLC ORDINARY 1 PENCE SHARES
21. Exercise price (if fixed at time of grant) or indication that price is to be fixed at the time of exercise
ONE PENCE
22. Total number of shares or debentures over which options held following notification
1,628,559
23. Any additional information
THE OPTION IS SUBJECT TO PERFORMANCE CONDITIONS MEASURING THE COMPANY'S TOTAL SHAREHOLDER RETURN (TSR) AGAISNT THE TSR OF THE FTSE SMALLCAP INDEX OVER A THREE YEAR PERIOD COMMENCING ON THE GRANT DATE
24. Name of contact and telephone number for queries
ZOE MCGOWAN 01480 437697
Name and signature of duly authorised officer of issuer responsible for making notification
ZOE MCGOWAN
Date of notification
3 JUNE 2008
END
Follow the stocks
